CathVision Unveils ECGenius™ System 3.4 and Welcomes New Board Member
CathVision Launches Latest Software Version and Welcomes New Leadership
CathVision ApS, the innovative medical technology firm behind advanced electrophysiology solutions for cardiac ablation, has announced the official launch of its ECGenius™ System Version 3.4. This new software version introduces a set of improvements designed primarily to enhance procedural workflows and boost the usability of the system for healthcare professionals working in electrophysiology (EP) labs.
Key Enhancements in ECGenius™ System 3.4
The latest software version of the ECGenius™ system includes significant upgrades that contribute to better patient care. The features now enable physicians to:
- - Effectively measure the validation period post-ablation, assisting them in assessing the impact of medications on patient outcomes.
- - Simultaneously view multiple signal components, which facilitates more accurate interpretations of nearfield signals during procedures.
- - Customize visual displays to optimize structured event annotations, helping professionals communicate vital information clearly and efficiently.
These enhancements are set to be rolled out to subscription-based customers in the United States promptly, with plans for expansion into the EU market scheduled for the current quarter, marking a significant step in CathVision’s commitment to advancing cardiac care.
New Board Appointment
In alignment with the company's strategic growth, CathVision announced the appointment of Wendy Dittmer as an independent director on its Board of Directors. Dittmer brings extensive experience from her previous leadership roles at Philips, where she focused on strategic partnerships, innovation, and the integration of analytic and medical device technologies. Her appointment is a testament to CathVision's dedication to solid governance as they expand their market outreach and strengthen clinical collaborations.
Mads Matthiesen, CEO of CathVision, expressed enthusiasm for these developments, stating, “We are at an exciting point in our journey, with our clinical modules progressing and our commercial system evolving through continuous software development. Welcoming Wendy Dittmer to the Board represents a strategic step forward in building the partnerships and perspectives we need to accelerate growth.”
About CathVision
CathVision has developed the groundbreaking intelligent EP recording system, which provides immediate and accurate physiological feedback verification during cardiac ablation procedures. This system seamlessly integrates into existing workflows, eliminating the need for additional mapping catheters, while allowing electrophysiologists to retain their preferred ablation catheter. Combining enhanced signal processing quality with CARDIALYTICS algorithms, practitioners can observe real-time changes in rhythm resulting from procedural steps, thereby receiving timely measurements and visual confirmations during pulmonary vein isolation (PVI) procedures.
Moreover, CathVision is advancing its unique method of classifying signal signatures in specific areas pertinent to persistent atrial fibrillation (AF), which could significantly improve the outcomes for patients with this challenging condition. To learn more about CathVision's innovations and impact in the electrophysiology field, visit www.cathvision.com.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.